Full-Time
Portfolio Manager
Maven Securities
201-500 employees
Proprietary-capital multi-strategy trading and market making
No salary listed
New York, NY, USA
In Person
 Finance & Banking (1) |
|---|
- 3+ years experience as a PM, or 4-5 years as an assistant PM
- Realised Sharpe >2.5
- Display track record of strategy
- Deep understanding of strategy
- Strong coding skills
- Strong researching skills
- Masters or PHD in scientific subject
Maven Securities trades and provides market liquidity across global financial markets using its own capital. It combines fundamental and quantitative methods to find trading opportunities and to execute trades efficiently from front office to settlements. The firm differentiates itself by using exclusively proprietary capital, strong risk controls, and a focus on technology to improve execution. Its goal is to earn sustainable profits while keeping markets liquid for institutional clients and other traders.
Company Size
201-500
Company Stage
N/A
Total Funding
N/A
Headquarters
London, United Kingdom
Founded
2011
Simplify's Take
What believers are saying
- MBX Biosciences' canvuparatide shows 63% Phase 2 response rate, targeting $61 stock.
- Stifel and UBS issue Buy ratings on MBX with $50-$60 targets for pipeline progress.
- Maven allocates internal capital flexibly, ensuring alignment and robust returns always.
What critics are saying
- MBX 4291 Phase 1b obesity data fails in Q4 2026, wiping biotech investment value.
- Canvuparatide Phase 3 stalls within 12 months, collapsing MBX's lead program valuation.
- MBX exhausts cash runway in 18 months, forcing dilutive raises that shrink Maven's stake.
What makes Maven Securities unique
- Deploys proprietary capital across discretionary, systematic, and market-making strategies.
- Integrates machine learning and cutting-edge tech for algorithmic trading excellence.
- Provides liquidity in global listed derivatives with tight pricing during volatility.
Help us improve and share your feedback! Did you find this helpful?
Benefits
401K Scheme
25 Days Annual Leave plus public holidays
Healthcare, Dental & Vision
Employee Volunteering Opportunities
Annual Discretionary Bonus
Company News
Maven Securities LTD has invested approximately $4 million in StandardAero, acquiring a stake of 150,000 shares as of the first quarter of 2023.
Maven Securities LTD acquired a new stake in Sotera Health in the 3rd quarter valued at approximately $1,670,000.
Soros Fund Management LLC acquired a new stake in Rithm Capital in the 3rd quarter valued at about $23,835,000.
Finally, Maven Securities LTD purchased a new stake in Rithm Capital in the 3rd quarter worth about $11,350,000.
Maven Securities LTD purchased a new stake in Wave Life Sciences in the third quarter worth $6,970,000.